Achmea Investment Management B.V. cut its stake in Clorox Co (NYSE:CLX) by 15.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 39,582 shares of the company’s stock after selling 7,143 shares during the quarter. Achmea Investment Management B.V.’s holdings in Clorox were worth $5,951,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently modified their holdings of CLX. Macquarie Group Ltd. raised its stake in shares of Clorox by 437,400.0% in the second quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock worth $236,688,000 after purchasing an additional 1,749,600 shares during the last quarter. Schroder Investment Management Group raised its stake in shares of Clorox by 57.0% in the second quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock worth $201,641,000 after purchasing an additional 547,070 shares during the last quarter. Unigestion Holding SA purchased a new stake in shares of Clorox in the second quarter worth approximately $73,819,000. Morgan Stanley raised its stake in shares of Clorox by 44.2% in the second quarter. Morgan Stanley now owns 1,101,380 shares of the company’s stock worth $148,962,000 after purchasing an additional 337,621 shares during the last quarter. Finally, FMR LLC raised its stake in shares of Clorox by 201.0% in the second quarter. FMR LLC now owns 472,179 shares of the company’s stock worth $63,863,000 after purchasing an additional 315,298 shares during the last quarter. 78.35% of the stock is owned by hedge funds and other institutional investors.
In other news, SVP Diego J. Barral sold 12,880 shares of the firm’s stock in a transaction on Tuesday, November 6th. The stock was sold at an average price of $157.98, for a total value of $2,034,782.40. Following the completion of the transaction, the senior vice president now directly owns 18,603 shares of the company’s stock, valued at $2,938,901.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 54,205 shares of the firm’s stock in a transaction on Tuesday, November 6th. The stock was sold at an average price of $157.39, for a total value of $8,531,324.95. Following the completion of the transaction, the chief operating officer now directly owns 37,044 shares of the company’s stock, valued at $5,830,355.16. The disclosure for this sale can be found here. Insiders sold 96,353 shares of company stock valued at $14,762,793 over the last ninety days. Corporate insiders own 1.40% of the company’s stock.
Shares of NYSE CLX opened at $158.77 on Friday. Clorox Co has a 1-year low of $113.57 and a 1-year high of $159.17. The firm has a market cap of $20.18 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 3.88 and a beta of 0.28. The company has a debt-to-equity ratio of 3.38, a current ratio of 1.07 and a quick ratio of 0.65.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.59 by $0.03. Clorox had a return on equity of 102.65% and a net margin of 13.59%. The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the company earned $1.46 earnings per share. Clorox’s revenue was up 4.2% compared to the same quarter last year. Analysts anticipate that Clorox Co will post 6.31 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Stockholders of record on Wednesday, October 31st will be issued a $0.96 dividend. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.42%. The ex-dividend date is Tuesday, October 30th. Clorox’s payout ratio is currently 61.34%.
Several brokerages have recently commented on CLX. UBS Group started coverage on Clorox in a research note on Wednesday, July 18th. They issued a “sell” rating and a $110.00 price objective for the company. BMO Capital Markets reaffirmed a “buy” rating and set a $153.00 price target on shares of Clorox in a research report on Friday, August 3rd. ValuEngine raised Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $171.00 price target for the company in a research report on Wednesday, October 3rd. Finally, Wells Fargo & Co increased their price target on Clorox from $135.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 17th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company. Clorox presently has an average rating of “Hold” and an average price target of $141.64.
ILLEGAL ACTIVITY WARNING: “Achmea Investment Management B.V. Has $5.95 Million Stake in Clorox Co (CLX)” was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/11/10/achmea-investment-management-b-v-has-5-95-million-stake-in-clorox-co-clx.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Discount Rate
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.